WebMar 1, 2024 · continuous, uncontrolled back-and-forth or rolling eye movements dizziness double vision drowsiness eye redness or pain generalized slowing of mental and …
Sumatriptan Drugs BNF NICE
Monotherapy of generalised tonic-clonic seizures or focal seizures with or without secondary generalisation. By mouth. Child 6–17 years. Initially 0.5–1 mg/kg once daily (max. per dose 25 mg) for 1 week, dose to be taken at night, then increased in steps of 250–500 micrograms/kg twice daily, dose to be increased by a … See more Alopecia; anaemia; anxiety; appetite abnormal; asthenia; behaviour abnormal; cognitive impairment; concentration impaired; confusion; … See more Eye inflammation; face oedema; glaucoma; hepatic disorders; limb discomfort; neutropenia; Raynaud's phenomenon; renal … See more Abnormal sensation in eye; anhidrosis; arrhythmias; aura; cerebellar syndrome; consciousness impaired; crying; drooling; dry eye; dysgraphia; … See more WebNov 24, 2024 · CHM review and update. In November 2013, we issued advice about switching between different manufacturers’ products of an oral antiepileptic drug. In September 2016, the Commission of Human ... new jersey pagans motorcycle club
Topiramate for migraines. Topiramate side effects at Patient
WebMar 1, 2024 · Topiramate may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. Make sure the doctor knows if you have trouble sleeping, get upset easily, have a big increase in energy, or start to act reckless. ... WebGeneric Name Topiramate DrugBank Accession Number DB00273 Background. Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. 4 It was initially approved by the FDA in 1996. In … WebBackground: Weight loss can occur during topiramate (TPM) treatment and it should be evaluated by clinicians, especially in children, whose growth could be compromised. In international literature, the reported body weight loss incidences linked to TPM therapy vary widely and, in some cases, are very conflicting. new jersey p3 legislation